AstraZeneca Bolsters Oncology Franchise with $1.5 Billion Global Licensing Deal for Dizal’s Zegfrovy
In a major strategic maneuver that underscores the shifting landscape of global pharmaceutical partnerships, AstraZeneca has announced a definitive agreement...
